Policy & Regulation
2 July 2025 - RedHill Biopharma Ltd (NASDAQ: RDHL), an Israeli specialty biopharmaceutical company, announced on Tuesday the initiation of patient recruitment into the Phase 2 study evaluating the eff...
1 July 2025 -

Sweden-based biopharmaceutical company Camurus AB (NASDAQ STO: CAMX) announced on Tuesday that it has received marketing authorisati...

1 July 2025 -

Clinical stage immuno-oncology company Genenta Science SPA (NASDAQ: GNTA) on Tuesday announced long-term follow-up data from its gl...

1 July 2025 - Sensorion (Euronext Growth Paris:ALSEN), a clinical-stage biotechnology company that specialises in hearing loss therapies, on Tuesday announced preliminary positive safety and efficacy ...
1 July 2025 - US pharmaceutical company Amgen (NASDAQ:AMGN) announced on Monday that the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its p...
1 July 2025 - TuHURA Biosciences Inc (NASDAQ:HURA), a Phase 3 immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, announced on Monday the successful c...